secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001654954-24-000269
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax Therapeutics announces 1-for-80 reverse stock split effective Jan 2, 2024
-------------------------------------------------------------------------------

- Reverse split at 1:80 ratio effective 5:00 pm ET on Jan 2, 2024; trading on Nasdaq split-adjusted Jan 3 under TENX.
- Pre-split shares: 23,862,434; post-split approximately 298,281 shares outstanding.
- No fractional shares issued; odd-lot holders receive one whole share for fractional interests.
- Primary purpose: regain compliance with Nasdaq minimum $1.00 bid price requirement (Rule 5550(a)(2)).
- Authorized shares unchanged at par value $0.0001; proportional adjustments to options and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495424000269/0001654954-24-000269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495424000269/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-000269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer